Trials / Unknown
UnknownNCT05277090
Bowel Preparation May Lead to a Higher Feasibility of Intestinal Infection
Bowel Preparation for Colonoscopy May Lead to a Higher Feasibility of Intestinal Infection: a Clinical and Basic Research
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Yanqing Li · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
An adequate bowel preparation is essential for a high quality of colonscopy. Nowdays, polyethyleneglyco is considered the most safe drug for bowel preparation, and is widely used around the world. However, previous study illustrated that bowel preparation by polyethyleneglyco could lead to qualitative changes in the intestinal microbiota both in mice and human. This study is aimed to investigate wether the changes in the intestinal microbiota could lead to a higher rate of intestinal infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 2L of polyethyleneglycol | 2L of polyethyleneglycol |
| DIETARY_SUPPLEMENT | inulin | 15g inulin per day |
| COMBINATION_PRODUCT | probiotic combination product | participants take 2L of polyethyleneglycol, subsequently take 15g probiotics combination product (including Bifidobacterium lactis, Lactobacillus plantarum, inlulin, Vitamin C) per day. The probiotic combination product, named "Mei Ri Yi Jun" was produced by Wedge Pharmaceuticals. |
Timeline
- Start date
- 2022-03-15
- Primary completion
- 2022-03-15
- Completion
- 2022-03-15
- First posted
- 2022-03-14
- Last updated
- 2022-03-14
Source: ClinicalTrials.gov record NCT05277090. Inclusion in this directory is not an endorsement.